Dr. David Hong, MD
Claim this profileM D Anderson Cancer Center
Expert in Tumors
Expert in Solid Tumors
23 reported clinical trials
47 drugs studied
Area of expertise
1Tumors
Global LeaderStage IV
Stage III
NTRK1 positive
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials David Hong, MD is currently running
Larotrectinib
for Advanced or Metastatic Cancer
This phase II trial studies the effect of larotrectinib in treating patients with NTRK gene amplification positive solid tumors that have spread to nearby tissues or lymph nodes (locally advanced) or other places in the body (metastatic). Larotrectinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 214 criteria
NK Cell Therapy + Chemotherapy
for Advanced Kidney, Lung, or Bone Cancer
To find a recommended dose of donated NK cells that can be given with lymphodepleting chemotherapy to patients with advanced renal cell carcinoma, mesothelioma, or osteosarcoma. The effects of this therapy will also be studied.
Recruiting1 award Phase 1 & 213 criteria
More about David Hong, MD
Clinical Trial Related3 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments David Hong, MD has experience with
- Pembrolizumab
- ADP-A2M4CD8
- Radiation Therapy
- VMD-928
- PBI-200
- Tisotumab Vedotin
Breakdown of trials David Hong, MD has run
Tumors
Solid Tumors
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Hong, MD specialize in?
David Hong, MD focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is David Hong, MD currently recruiting for clinical trials?
Yes, David Hong, MD is currently recruiting for 11 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that David Hong, MD has studied deeply?
Yes, David Hong, MD has studied treatments such as Pembrolizumab, ADP-A2M4CD8, Radiation Therapy.
What is the best way to schedule an appointment with David Hong, MD?
Apply for one of the trials that David Hong, MD is conducting.
What is the office address of David Hong, MD?
The office of David Hong, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.